Equities
Health CareMedical Equipment and Services
  • Price (EUR)24.37
  • Today's Change-0.73 / -2.91%
  • Shares traded1.31m
  • 1 Year change-11.61%
  • Beta0.5706
Data delayed at least 15 minutes, as of Nov 08 2024 16:36 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Amplifon SpA had net income fall -13.10% from 178.53m to 155.14m despite a 6.65% increase in revenues from 2.12bn to 2.26bn. An increase in the selling, general and administrative costs as a percentage of sales from 33.64% to 36.30% was a component in the falling net income despite rising revenues.
Gross margin23.55%
Net profit margin6.61%
Operating margin11.32%
Return on assets4.13%
Return on equity14.25%
Return on investment6.24%
More ▼

Cash flow in EURView more

In 2023, Amplifon SpA increased its cash reserves by 7.51%, or 13.49m. The company earned 413.54m from its operations for a Cash Flow Margin of 18.30%. In addition the company used 261.48m on investing activities and also paid 135.06m in financing cash flows.
Cash flow per share1.98
Price/Cash flow per share12.26
Book value per share4.96
Tangible book value per share-5.56
More ▼

Balance sheet in EURView more

Amplifon SpA has a Debt to Total Capital ratio of 60.64%, a lower figure than the previous year's 96.88%.
Current ratio0.4746
Quick ratio0.4043
Total debt/total equity1.54
Total debt/total capital0.6064
More ▼

Growth rates in EUR

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -11.67%. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)0.64%
Div growth rate (5 year)15.68%
Payout ratio (TTM)41.93%
EPS growth(5 years)8.96
EPS (TTM) vs
TTM 1 year ago
-6.44
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.